IP Verse

Crystalline Solid Forms Of 6-Carboxy-2-(3,5-Dichlorophenyl)-Benzoxazole For Use As A Medicament

Patent No. EP4349406 (titled "Crystalline Solid Forms Of 6-Carboxy-2-(3,5-Dichlorophenyl)-Benzoxazole For Use As A Medicament") was filed by Pfizer on Aug 31, 2015. The application was issued on Dec 3, 2025.

Patent Summary

Patent Family

Patent Family

Patent Oppositions (5)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
GRUNECKER PATENT UND RECHTSANWALTE PARTG MBBSep 3, 2026GRUNECKER PATENT
HAMM&WITTKOPP PATENTANWÄLTE PARTMBBSep 3, 2026HAMM&WITTKOPP PATENTANWÄLTE PARTMBB
HOLLATZSep 3, 2026TER MEER UND PARTNER
DEVA HOLDINGSep 2, 2026-
QUIMICA SINTETICASep 2, 2026BARDEHLE PAGENBERG SL

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP4349406

PFIZER
Application Number
EP24152053A
Filing Date
Aug 31, 2015
Status
Granted And Under Opposition
Oct 31, 2025
Publication Date
Dec 3, 2025
External Links
Slate, Register , Google Patents